Submitted by Anonymous (not verified) on 24 November 2023 - 13:47
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 23/11/2015, Revision: 18, Status: Authorised
Source: